Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival

Sugarcone Biotech LLC is the premier immuno-oncology strategic consulting and investment firm. Our success rate in launching, building and creating value across diverse immune oncology companies is stunning. Join founder Paul Rennert at the CRI-CIMT-EATI-AACR sponsored conference, Cancer Immunotherapy: Translating Science Into Survival, to explore ways that we can add value to your company and investments.

Paul will be onsite at the Times Square Sheraton September 16 – 19.

Email rennertp@sugarconebiotech.com or text/call 1-508-282-6370 to arrange a meeting.

see you in NYC -

Screen Shot 2015-08-31 at 7.27.40 AM

 

CRI-CIMT-EATI-AACR

CRI-CIMT-EATI-AACR